Adaptation And Implementation Of Who S Multisectoral Accountability Framework To End Tb Maf Tb

Adaptation and implementation of WHO’s multisectoral accountability framework to end TB (MAF-TB)

The Operational guidance on adaptation and implementation of WHO’s Multisectoral Accountability Framework to end TB (MAF-TB) provides practical advice on key approaches and interventions needed to establish the MAF-TB at the national (and local) levels with concrete country examples, best practices and case studies under each suggested approach and interventions. It is intended for use by all stakeholders involved in their national TB response, including ministries of health and other relevant government ministries and bodies, national TB programmes (or their equivalents in ministries of health), other relevant national programmes, parliamentarians, the private sector, international organizations, nongovernmental and civil society organizations and TB-affected communities involved in planning, implementation, monitoring and evaluation and review of the TB response. The stakeholders involved may vary across countries depending on several factors, including the epidemiology and determinants of TB, the institutional arrangements for TB care and prevention and the degree of devolution of the political and health governance system.

Adaptation and implementation of WHO’s multisectoral accountability framework to end TB (MAF-TB)

Global tuberculosis report 2023

The Global Tuberculosis Report 2023, published by the World Health Organization, provides a comprehensive overview of the current status of the tuberculosis epidemic. The report highlights the global commitments, strategies, and targets set by world leaders to combat TB. It presents key findings and messages, emphasizing the importance of translating political commitments into actionable plans at the country level. The report includes data collected from 215 countries and areas, offering insights into TB incidence, mortality, diagnosis, treatment, prevention, and financing. The intended audience includes policymakers, healthcare professionals, and researchers involved in TB response and public health initiatives.